Global prevalence of short bowel syndrome–associated intestinal failure in adults and children: A targeted literature review and analysis

Documents similaires

• Teduglutide improves liver chemistries in short bowel syndrome–associated intestinal failure: Post hoc analysis
  par: Dejan Micic, et autres
  Publié: (2024)
• Short bowel syndrome–associated intestinal failure patient experience: A mixed‐method study leveraging an online patient community
  par: Brian Po‐Han Chen, et autres
  Publié: (2025)
• Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS‐1 phase 3 trial
  par: David F. Mercer, et autres
  Publié: (2026)
• Current treatment options for adult patients with short bowel syndrome: Do prebiotics, probiotics, and synbiotics play a role?
  par: Elizabeth Reznik, et autres
  Publié: (2025)
• Gut instinct: Navigating the landscape of parenteral support in short bowel syndrome
  par: Jamie Bering, et autres
  Publié: (2024)